These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 35609832
1. Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation method. Beig A, Ackermann R, Wang Y, Schutzman R, Schwendeman SP. Int J Pharm; 2022 Aug 25; 624():121842. PubMed ID: 35609832 [Abstract] [Full Text] [Related]
2. Development and characterization of composition-equivalent formulations to the Sandostatin LAR® by the solvent evaporation method. Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, Wang Y, Schwendeman SP. Drug Deliv Transl Res; 2022 Mar 25; 12(3):695-707. PubMed ID: 34215997 [Abstract] [Full Text] [Related]
3. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres. Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, Wang Y, Qin B, Schwendeman SP. Mol Pharm; 2020 Nov 02; 17(11):4141-4151. PubMed ID: 32876463 [Abstract] [Full Text] [Related]
4. In vitro performance of composition-equivalent PLGA microspheres encapsulating exenatide acetate by solvent evaporation. Chandrashekar A, Beig A, Wang Y, Schwendeman SP. Int J Pharm; 2023 Aug 25; 643():123213. PubMed ID: 37423376 [Abstract] [Full Text] [Related]
5. Sustained-release delivery of octreotide from biodegradable polymeric microspheres. Rhee YS, Sohn M, Woo BH, Thanoo BC, DeLuca PP, Mansour HM. AAPS PharmSciTech; 2011 Dec 25; 12(4):1293-301. PubMed ID: 21948321 [Abstract] [Full Text] [Related]
6. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres. Ghassemi AH, van Steenbergen MJ, Barendregt A, Talsma H, Kok RJ, van Nostrum CF, Crommelin DJ, Hennink WE. Pharm Res; 2012 Jan 25; 29(1):110-20. PubMed ID: 21744173 [Abstract] [Full Text] [Related]
7. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release. Liang D, Frank S, Schwendeman SP. Drug Deliv Transl Res; 2024 Mar 25; 14(3):696-704. PubMed ID: 38038895 [Abstract] [Full Text] [Related]
8. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres. Wang J, Wang BM, Schwendeman SP. Biomaterials; 2004 May 25; 25(10):1919-27. PubMed ID: 14738856 [Abstract] [Full Text] [Related]
9. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide. Zhou J, Walker J, Ackermann R, Olsen K, Hong JKY, Wang Y, Schwendeman SP. Mol Pharm; 2020 May 04; 17(5):1502-1515. PubMed ID: 32074448 [Abstract] [Full Text] [Related]
10. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing. Witschi C, Doelker E. J Control Release; 1998 Feb 12; 51(2-3):327-41. PubMed ID: 9685930 [Abstract] [Full Text] [Related]
11. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres. Wang J, Wang BM, Schwendeman SP. J Control Release; 2002 Aug 21; 82(2-3):289-307. PubMed ID: 12175744 [Abstract] [Full Text] [Related]
12. Mechanistic evaluation of the initial burst release of leuprolide from spray-dried PLGA microspheres. Schutzman R, Shi NQ, Olsen KF, Ackermann R, Tang J, Liu YY, Hong JKY, Wang Y, Qin B, Schwendeman A, Schwendeman SP. J Control Release; 2023 Sep 21; 361():297-313. PubMed ID: 37343723 [Abstract] [Full Text] [Related]
13. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Blanco D, Alonso MJ. Eur J Pharm Biopharm; 1998 May 21; 45(3):285-94. PubMed ID: 9653633 [Abstract] [Full Text] [Related]
14. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions. Murty SB, Goodman J, Thanoo BC, DeLuca PP. AAPS PharmSciTech; 2003 Oct 13; 4(4):E50. PubMed ID: 15198545 [Abstract] [Full Text] [Related]
15. Pore change during degradation of octreotide acetate-loaded PLGA microspheres: The effect of polymer blends. Wang T, Xue P, Wang A, Yin M, Han J, Tang S, Liang R. Eur J Pharm Sci; 2019 Oct 01; 138():104990. PubMed ID: 31302216 [Abstract] [Full Text] [Related]
16. Microspheres prepared with PLGA blends for delivery of dexamethasone for implantable medical devices. Wang Y, Gu B, Burgess DJ. Pharm Res; 2014 Feb 01; 31(2):373-81. PubMed ID: 23949251 [Abstract] [Full Text] [Related]
17. Preparation and in vitro/in vivo evaluation of PLGA microspheres containing norquetiapine for long-acting injection. Park CW, Lee HJ, Oh DW, Kang JH, Han CS, Kim DW. Drug Des Devel Ther; 2018 Feb 01; 12():711-719. PubMed ID: 29670329 [Abstract] [Full Text] [Related]
18. Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents. Wang FJ, Wang CH. J Control Release; 2002 Jun 17; 81(3):263-80. PubMed ID: 12044566 [Abstract] [Full Text] [Related]
19. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres. Oh JE, Nam YS, Lee KH, Park TG. J Control Release; 1999 Feb 22; 57(3):269-80. PubMed ID: 9895414 [Abstract] [Full Text] [Related]
20. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A. Colloids Surf B Biointerfaces; 2009 Nov 01; 74(1):340-9. PubMed ID: 19717287 [Abstract] [Full Text] [Related] Page: [Next] [New Search]